New hope for Tough-to-Treat lung cancer: experimental drugs enter Mid-Stage trial
NCT ID NCT05924841
Summary
This study is testing two new drugs, BL-B01D1 and SI-B003, given alone and together, for people with advanced small cell lung cancer that has spread. The main goal is to see if these treatments shrink tumors and are safe for patients. It will enroll about 100 adults whose cancer has progressed after standard treatments or who are newly diagnosed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jilin Cancer Hospital
RECRUITINGChangchun, Jilin, 130000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.